av/panbela-therapeutics--big.svg

COM:PANBELA

Panbela Therapeutics

  • Stock

Last Close

0.35

22/11 20:00

Market Cap

1.71M

Beta: -

Volume Today

5.21K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
973.81K
-
1.36M
39.35%
-1.64M
-
cost of revenue
558.47K
-
595.15K
6.57%
5.44M
814.72%
5.17M
5.07%
6.02M
16.41%
3.89M
35.32%
4.32M
11.08%
5.75M
33.13%
10.01M
73.97%
34.09M
240.59%
25.65M
24.77%
gross profit
415.35K
-
761.84K
83.42%
-5.44M
814.58%
-5.17M
5.07%
-6.02M
16.41%
-3.89M
35.32%
-4.32M
11.08%
-5.75M
33.13%
-10.01M
73.97%
-35.73M
256.95%
-25.65M
28.22%
selling and marketing expenses
-217K
-
general and administrative expenses
329.88K
-
837.24K
153.80%
2.81M
235.51%
2.66M
5.16%
3.42M
28.49%
2.11M
38.42%
1.97M
6.40%
3.25M
64.67%
4.59M
41.18%
6.04M
31.76%
5.03M
16.73%
selling general and administrative expenses
329.88K
-
837.24K
153.80%
2.59M
209.59%
2.66M
2.78%
3.42M
28.49%
2.11M
38.42%
1.97M
6.40%
3.25M
64.67%
4.59M
41.18%
6.04M
31.76%
5.03M
16.73%
research and development expenses
279.79K
-
2.85M
-
2.50M
12.20%
2.59M
3.55%
1.78M
31.24%
2.35M
31.74%
2.50M
6.64%
5.42M
116.49%
28.05M
417.22%
20.61M
26.51%
other expenses
-508K
-
-99K
80.51%
605K
711.11%
-602K
199.50%
-682K
13.29%
cost and expenses
1.17M
-
1.43M
22.62%
5.44M
280.06%
5.17M
5.07%
6.02M
16.41%
3.84M
36.22%
4.32M
12.64%
5.75M
33.13%
10.01M
73.97%
34.09M
240.59%
51.29M
50.45%
operating expenses
609.67K
-
837.24K
37.33%
5.44M
550.23%
5.17M
5.07%
6.02M
16.41%
3.84M
36.22%
4.32M
12.64%
5.75M
33.13%
10.01M
73.97%
34.09M
240.59%
25.65M
24.77%
interest expense
35.89K
-
35.53K
1.01%
183K
415.10%
180K
1.64%
1.62M
798.33%
1.81M
12.18%
2.19M
20.95%
17K
99.23%
11K
35.29%
288K
2,518.18%
-317K
210.07%
ebitda
-167.12K
-
-61.82K
63.01%
-5.44M
8,693.56%
-5.17M
4.97%
-6.01M
16.43%
-4.34M
27.76%
-4.42M
1.75%
-5.15M
16.47%
-10.61M
106.10%
-34.76M
227.56%
-51.29M
47.56%
operating income
-194.32K
-
-75.40K
61.20%
-5.44M
7,120.35%
-5.17M
5.07%
-6.02M
16.41%
-3.89M
35.32%
-4.32M
11.08%
-5.75M
33.13%
-10.01M
73.97%
-34.09M
240.59%
-51.29M
50.45%
depreciation and amortization
8.79K
-
9.58K
8.92%
8K
16.48%
2K
75%
1K
50%
-454K
45,500%
-99K
78.19%
605K
711.11%
-602K
199.50%
-668K
10.96%
total other income expenses net
-17.48K
-
-31.52K
80.36%
-64K
103.01%
-107K
67.19%
-3.28M
2,963.55%
-508K
84.50%
-2.29M
351.38%
691K
130.14%
-613K
188.71%
-956K
55.95%
25.84M
2,803.45%
income before tax
-211.80K
-
-106.92K
49.52%
-5.68M
5,215.04%
-5.45M
4.05%
-10.91M
100.07%
-6.16M
43.55%
-6.62M
7.40%
-5.06M
23.46%
-10.62M
109.82%
-35.05M
229.94%
-25.45M
27.39%
income tax expense
220
-
121
45%
-756K
624,893.39%
-341K
54.89%
-536K
57.18%
-254K
52.61%
-415K
63.39%
-295K
28.92%
-488K
65.42%
-116K
76.23%
-186K
60.34%
net income
-212.02K
-
-107.04K
49.51%
-4.93M
4,502.78%
-5.11M
3.75%
-10.37M
102.93%
-5.91M
43.08%
-6.20M
5.00%
-4.77M
23.10%
-10.13M
112.56%
-34.93M
244.68%
-25.26M
27.68%
weighted average shs out
120
-
120
0%
1.17K
876.67%
2.59K
120.90%
2.97K
14.75%
3.88K
30.76%
4.75K
22.27%
6.44K
35.66%
9.75K
51.35%
514.37K
5,173.96%
weighted average shs out dil
120
-
120
0%
1.17K
876.67%
2.59K
120.90%
2.97K
14.75%
3.88K
30.76%
4.75K
22.27%
6.44K
35.66%
9.75K
51.35%
514.37K
5,173.96%
eps
-1.77K
-
-892.03
49.51%
-4.20K
371.28%
-1.97K
53.03%
-3.49K
76.84%
-1.52K
56.47%
-1.31K
14.12%
-739.91
43.31%
-1.04K
40.45%
-67.91
93.46%
-232.43K
342,161.15%
epsdiluted
-1.77K
-
-892.03
49.51%
-4.20K
371.28%
-1.97K
53.03%
-3.49K
76.84%
-1.52K
56.47%
-1.31K
14.12%
-739.91
43.31%
-1.04K
40.45%
-67.91
93.46%
-232.43K
342,161.15%

All numbers in (except ratios and percentages)